47 Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patients with hypercholesterolaemia (MENDEL): a randomised, double-blind, placebo-controlled, phase 2 study.
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)61771-1/abstract
46 Transcriptional mechanisms controlling gene expression in the heart’s outer layer are exploited for cardiac repair.
http://www.sciencemag.org/content/338/6114/1599.abstract
45 Functional screening identifies miRNAs inducing cardiac regeneration.
http://www.nature.com/nature/journal/v492/n7429/full/nature11739.html
44 Poly-sulfobetaine surface modification on a vascular catheter inhibits microbial adherence and thrombosis.
http://stm.sciencemag.org/content/4/153/153ra132.abstract
43 Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts.
http://www.nature.com/nature/journal/v489/n7415/full/nature11317.html
42 Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors.
http://www.nature.com/nm/journal/v18/n9/abs/nm.2891.html
41 APJ acts as a dual receptor in cardiac hypertrophy.
http://www.nature.com/nature/journal/v488/n7411/full/nature11263.html
40 An intramyocardial microenvironment was created using nanofibers and VEGF for endogenous cardiac repair after infarction.
http://stm.sciencemag.org/content/4/146/146ra109.abstract
39 Nanoparticles carrying a drug that dissolves blood clots disintegrate at sites of stenosis.
http://www.sciencemag.org/content/337/6095/738.abstract
38 Myocardial infarction accelerates atherosclerosis.
http://www.nature.com/nature/journal/v487/n7407/full/nature11260.html
|
